MaaT Pharma SA
EPA:MAAT.PA
7.78 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 24.28 | 35.248 | 43.304 | 19.913 | 5.411 | 3.6 | 7.35 |
Short Term Investments
| 0.034 | 0.063 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 24.314 | 35.311 | 43.304 | 19.913 | 5.411 | 3.6 | 7.35 |
Net Receivables
| 5.164 | 4.238 | 2.39 | 0 | 1.499 | 0.794 | 0.004 |
Inventory
| 0.19 | 0.047 | 0.033 | -0.097 | 0.027 | 0 | 0.029 |
Other Current Assets
| 2.326 | 2.528 | 1.541 | 0.627 | 0.074 | 0.332 | 1.409 |
Total Current Assets
| 31.994 | 42.124 | 47.269 | 22.193 | 6.984 | 4.726 | 8.792 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 9.172 | 0.966 | 1.107 | 1.097 | 0.428 | 0.391 | 0.313 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0.044 |
Intangible Assets
| 1.343 | 1.2 | 0.806 | 0.75 | 0.699 | 0.709 | 0 |
Goodwill and Intangible Assets
| 1.343 | 1.2 | 0.806 | 0.75 | 0.699 | 0.709 | 0.044 |
Long Term Investments
| 0.422 | 0.436 | 0.238 | 0.237 | 0.059 | 0.059 | 0 |
Tax Assets
| -0.222 | -0.436 | -0.238 | -0.237 | -0.059 | -0.059 | 0 |
Other Non-Current Assets
| 0 | 0.436 | 0.237 | 0.236 | 0.058 | 0.059 | 0.113 |
Total Non-Current Assets
| 10.937 | 2.602 | 2.15 | 2.083 | 1.185 | 1.159 | 0.47 |
Total Assets
| 42.931 | 44.726 | 49.42 | 24.276 | 8.17 | 5.885 | 9.262 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 6.349 | 4.507 | 0.034 | 1.404 | 1.678 | 1.42 | 1.144 |
Short Term Debt
| 3.398 | 2.969 | 1.233 | 0.862 | 0.549 | 0.427 | 0.001 |
Tax Payables
| 0.057 | 0.047 | 0.034 | 0.031 | 0.018 | 0.014 | 0 |
Deferred Revenue
| 0.057 | 0 | 0.727 | 0.525 | 0.304 | 0 | 0 |
Other Current Liabilities
| 1.604 | 1.694 | 2.675 | 0.037 | 0.387 | 0.378 | 0.308 |
Total Current Liabilities
| 11.522 | 9.217 | 4.703 | 2.859 | 2.632 | 2.239 | 1.452 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 10.62 | 8.356 | 4.531 | 5.215 | 9.916 | 2.175 | 1.723 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.323 | 0.342 | 0.33 | 0.265 | 0.187 | 0.202 | 0.818 |
Total Non-Current Liabilities
| 10.943 | 8.698 | 4.861 | 5.48 | 10.103 | 2.377 | 2.542 |
Total Liabilities
| 22.465 | 17.915 | 9.564 | 8.339 | 12.735 | 4.616 | 3.994 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1.162 | 0.994 | 0.988 | 0.659 | 0.289 | 0.289 | 0.289 |
Retained Earnings
| -18.073 | -12.507 | -7.596 | -4.627 | -5.199 | -11.012 | -7 |
Accumulated Other Comprehensive Income/Loss
| -0 | 0 | 0 | -0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 37.161 | 38.187 | 46.464 | 19.905 | 0.345 | 11.992 | 11.979 |
Total Shareholders Equity
| 20.466 | 26.811 | 39.856 | 15.937 | -4.565 | 1.269 | 5.268 |
Total Equity
| 20.466 | 26.811 | 39.856 | 15.937 | -4.565 | 1.269 | 5.268 |
Total Liabilities & Shareholders Equity
| 42.931 | 44.726 | 49.42 | 24.276 | 8.17 | 5.885 | 9.262 |